Home LiteratureArticle Details
PMID: 12037155 Published · ppublish English Editorial Comment

Can we change the course of beta-cell destruction in type 1 diabetes?

The New England journal of medicine ·Vol. 346 ·No. 22 ·2002-05-30 ·Pages 1740-2

Gale EA

Abstract

暂无摘要

MeSH Terms
Antibodies, Monoclonal/therapeutic use CD3 Complex/immunology Diabetes Mellitus, Type 1/drug therapy,genetics,prevention & control Family Humans Hypoglycemic Agents/therapeutic use Insulin/therapeutic use Islets of Langerhans/immunology Risk Factors
Chemicals
Antibodies, Monoclonal CD3 Complex Hypoglycemic Agents Insulin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Gale Edwin A M
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
DOI
10.1056/NEJM200205303462211
Published
2002-05-30
Pages
1740-2
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 12037147
CommentOn
PMID: 12037148
CommentIn
PMID: 12362018
External Links
PubMed source DOI: 10.1056/NEJM200205303462211 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2